Akihiro Shindo
0000-0002-1006-4943
1 paper found
Refreshing results…
Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations
Missing publications? Search for publications with a matching author name.